Related Experiment Video
Updated: Sep 17, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Multiple colorectal tumors. An appraisal of natural history and therapeutic options
Abstract:
The clinical course of 101 patients with multiple colorectal carcinomas treated during a 15 year period is documented; 2.8 percent of all patients with colorectal cancer had metachronous tumors and 1.7 percent had synchronous lesions. The median interval between metachronous tumors was 9 years. The symptom duration was shorter before discovery of the second metachronous tumors, yet the second tumors were more malignant than the primary ones. Patients with synchronous tumors were older than those with single colon cancers or initial metachronous lesions. Synchronous tumors were more apt to occur on the right side of the colon than single tumors. Adenomatous polyps were present in the resected specimens 37 to 63 percent of the time. The overall uncorrected 5 year survival rate was only 21 percent. Among 20 patients having subtotal colectomy, the operative mortality was 10 percent. Eleven of 18 survivors of subtotal colectomy were free of disease 2 to 13 years later (average 5.5).
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
04:09The Pocket-Creation Procedure of Endoscopic Submucosal Dissection for Large Rectal Laterally Spreading Tumors
Published on: February 13, 2026